Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
Online Access: | https://doi.org/10.1002/trc2.12388 |
_version_ | 1797774699843813376 |
---|---|
author | Christopher H. Van Dyck Ryan S. O'Dell Adam P. Mecca |
author_facet | Christopher H. Van Dyck Ryan S. O'Dell Adam P. Mecca |
author_sort | Christopher H. Van Dyck |
collection | DOAJ |
first_indexed | 2024-03-12T22:24:56Z |
format | Article |
id | doaj.art-aa14cf8aab5c4577aeab36a9090b8c73 |
institution | Directory Open Access Journal |
issn | 2352-8737 |
language | English |
last_indexed | 2024-03-12T22:24:56Z |
publishDate | 2023-04-01 |
publisher | Wiley |
record_format | Article |
series | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
spelling | doaj.art-aa14cf8aab5c4577aeab36a9090b8c732023-07-22T06:46:06ZengWileyAlzheimer’s & Dementia: Translational Research & Clinical Interventions2352-87372023-04-0192n/an/a10.1002/trc2.12388Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trialsChristopher H. Van Dyck0Ryan S. O'Dell1Adam P. Mecca2Department of Psychiatry Alzheimer's Disease Research Unit, Yale School of Medicine New Haven Connecticut USADepartment of Psychiatry Alzheimer's Disease Research Unit, Yale School of Medicine New Haven Connecticut USADepartment of Psychiatry Alzheimer's Disease Research Unit, Yale School of Medicine New Haven Connecticut USAhttps://doi.org/10.1002/trc2.12388 |
spellingShingle | Christopher H. Van Dyck Ryan S. O'Dell Adam P. Mecca Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
title | Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials |
title_full | Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials |
title_fullStr | Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials |
title_full_unstemmed | Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials |
title_short | Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials |
title_sort | disease severity and minimal clinically important differences in clinical outcome assessments for alzheimer s disease clinical trials |
url | https://doi.org/10.1002/trc2.12388 |
work_keys_str_mv | AT christopherhvandyck diseaseseverityandminimalclinicallyimportantdifferencesinclinicaloutcomeassessmentsforalzheimersdiseaseclinicaltrials AT ryansodell diseaseseverityandminimalclinicallyimportantdifferencesinclinicaloutcomeassessmentsforalzheimersdiseaseclinicaltrials AT adampmecca diseaseseverityandminimalclinicallyimportantdifferencesinclinicaloutcomeassessmentsforalzheimersdiseaseclinicaltrials |